Benzodrocortisone: Difference between revisions
Appearance
Content deleted Content added
image, etc. |
WildCation (talk | contribs) Drugbox edits: Added CSID |
||
Line 39: | Line 39: | ||
| DrugBank = |
| DrugBank = |
||
| ChemSpiderID_Ref = |
| ChemSpiderID_Ref = |
||
| ChemSpiderID = |
| ChemSpiderID = 107004 |
||
| UNII = |
| UNII = |
||
| KEGG = |
| KEGG = |
Revision as of 13:57, 4 September 2017
Clinical data | |
---|---|
Other names | Hydrocortisone 17-benzoate; 11β,17α,21-Trihydroxypregn-4-ene-3,20-dione 17-benzoate; 17α-Benzoyloxypregn-4-ene-11α-ol-3,20-dione |
Drug class | Corticosteroid; Glucocorticoid |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C28H34O6 |
Molar mass | 466.574 g·mol−1 |
3D model (JSmol) | |
| |
|
Benzodrocortisone, also known as hydrocortisone 17-benzoate, is a synthetic glucocorticoid corticosteroid which was assigned an INN in 2016 and has yet to be marketed.[1]
References
- ^ World Health Organization (2016). "Proposed INN: List 116" (PDF). World Health Organization. Retrieved 2017-07-03.